<p>Palomar Holdings, Inc.（纳斯达克代码：PLMR - 获取免费报告）在覆盖该公司的八家研究机构中获得了 “适度买入” 的平均评级，Marketbeat Ratings 报告称。三位研究分析师对该股票给予了持有建议，五位分析师则给予了买入建议。在过去一年中，覆盖该股票的分析师的平均 12 个月目标价格为 157.6667 美元。</p>
<ul>
<li>下跌超过 80%，宠物保险公司 Trupanion 值得冒险溢价吗？</li>
</ul>
<p>几位分析师对该股票发表了看法。Weiss Ratings 在 10 月 8 日（星期三）的研究报告中重新发布了对 Palomar 股票的 “持有（c+）” 评级。Evercore ISI 在 10 月 1 日（星期三）的报告中将 Palomar 的目标价从 168.00 美元下调至 134.00 美元，并对该股票设定了 “持平” 评级。Keefe, Bruyette &amp; Woods 在 11 月 11 日（星期二）的报告中将 Palomar 的目标价从 164.00 美元上调至 170.00 美元，并给予该公司 “跑赢大盘” 的评级。摩根大通在 11 月 10 日（星期一）的研究报告中将 Palomar 的目标价从 137.00 美元上调至 145.00 美元，并给予该股票 “超配” 的评级。最后，华尔街 Zen 在 12 月 20 日（星期六）的研究报告中将 Palomar 的评级从 “买入” 下调至 “持有”。</p>
<p><strong>阅读我们最新的 PLMR 股票报告</strong></p>
<h2>Palomar 价格表现</h2>
<ul>
<li>3 只小盘股可能有一天会成为大盘股</li>
</ul>
<p>NASDAQ PLMR 的股票在周四以 136.29 美元开盘。该股票的市值为 36.1 亿美元，市盈率为 21.26，贝塔值为 0.50。Palomar 的 52 周低点为 98.42 美元，52 周高点为 175.85 美元。该公司的 50 日简单移动平均线为 122.35 美元，200 日简单移动平均线为 127.96 美元。</p>
<p>Palomar（纳斯达克代码：PLMR - 获取免费报告）最近于 12 月 16 日（星期五）公布了季度财报。该公司报告每股收益（EPS）为 0.07 美元。Palomar 的净利润率为 22.59%，股本回报率为 21.93%。该公司在本季度的收入为 6574 万美元。整体来看，股票分析师预计 Palomar 在当前财政年度的每股收益为 5.99 美元。</p>
<h2>内部活动</h2>
<p>在 Palomar 的其他新闻中，首席财务官 T Christopher Uchida 在 11 月 18 日（星期二）出售了 782 股该股票。股票以平均价格 128.84 美元出售，总交易额为 100,752.88 美元。出售完成后，首席财务官持有该公司 7916 股股票，价值 1,019,897.44 美元。这代表其持股减少了 8.99%。该交易在向 SEC 提交的文件中披露，相关信息可在 SEC 网站上找到。此外，首席执行官 Mac Armstrong 在 11 月 21 日（星期五）出售了 5000 股该公司的股票。股票以平均价格 122.86 美元出售，总交易额为 614,300.00 美元。出售完成后，首席执行官直接持有该公司 358,388 股股票，价值约 44,031,549.68 美元。此交易代表其持股减少了 1.38%。该交易的披露信息可在 SEC 文件中找到。在上个季度，内部人士共出售了 14,803 股公司股票，价值 1,768,671 美元。3.70% 的股票由公司内部人士持有。</p>
<h2>Palomar 的机构交易</h2>
<p>几家大型投资者最近调整了对 PLMR 的持股。Dynamic Technology Lab Private Ltd 在第一季度购买了 Palomar 的新头寸，价值约 314,000 美元。Advisors Asset Management Inc.在第一季度将其在 Palomar 的持股增加了 867.0%。Advisors Asset Management Inc.现在拥有 8229 股该公司的股票，价值 1,128,000 美元，此前在上个季度又购买了 7378 股。Trexquant Investment LP 在第一季度购买了 Palomar 的新头寸，价值 591,000 美元。Coppell Advisory Solutions LLC 在第一季度将其在 Palomar 的持股增加了 3912.3%。Coppell Advisory Solutions LLC 现在拥有 8787 股该公司的股票，价值 1,205,000 美元，此前在上个季度又购买了 8568 股。最后，Alliancebernstein L.P.在第一季度将其在 Palomar 的持股增加了 322.4%。Alliancebernstein L.P.现在拥有 127,383 股该公司的股票，价值 17,462,000 美元，此前在上个季度又购买了 97,226 股。90.25% 的股票由机构投资者持有。</p>
<h2>关于 Palomar</h2>
<p>（获取免费报告）</p>
<p>Palomar Holdings, Inc. 纳斯达克：PLMR 是一家专注于为美国自筹资金的雇主健康计划提供医疗止损保险和相关行政服务的专业保险控股公司。该公司通过两个主要业务部门——医疗止损和专业项目管理，提供量身定制的风险保护和全面的项目管理。</p>
<p>在其医疗止损部门，Palomar 承保旨在保护自保雇主免受超过预定保留水平的灾难性医疗索赔的超额和总额止损保单。</p>
<h2>精选文章</h2>
<ul>
<li>我们更看好的五只股票比 Palomar 更好</li>
<li>请勿删除，立即阅读</li>
<li>投资者警报：微型 “3 美元人工智能奇迹股票” 即将爆发</li>
<li>是否可以从资本利得税中扣除任何费用？</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
<li>忘记人工智能，这将是下一个重大科技突破</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UExNUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UExNUg"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Palomar 吗？</h2>
<p>在你考虑 Palomar 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Palomar 并不在名单上。</p>
<p>虽然 Palomar 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

PLMR

<p>Palomar Holdings, Inc.（纳斯达克代码：PLMR）获得了八家研究公司的平均 “适度买入” 评级。分析师设定的 12 个月平均目标价为 157.67 美元。最近的分析师行动包括 Evercore ISI、Keefe, Bruyette & Woods 和摩根大通的目标价调整。内部交易活动包括首席财务官 T Christopher Uchida 和首席执行官 Mac Armstrong 的股票出售。机构投资者已显著调整其在公司的持股。Palomar 是一家专注于医疗止损保险的专业保险控股公司</p>

<p>Palomar Holdings, Inc. (NASDAQ:PLMR - Get Free Report) has earned an average rating of &#34;Moderate Buy&#34; from the eight research firms that are covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month target price among analysts that have covered the stock in the last year is $157.6667.</p>
<div class="lb-trans"><p>Palomar Holdings, Inc.（纳斯达克代码：PLMR - 获取免费报告）在覆盖该公司的八家研究机构中获得了 “适度买入” 的平均评级，Marketbeat Ratings 报告称。三位研究分析师对该股票给予了持有建议，五位分析师则给予了买入建议。在过去一年中，覆盖该股票的分析师的平均 12 个月目标价格为 157.6667 美元。</p>
</div><ul>
<li>Down Over 80%, is Pet Insurer Trupanion Worth the Risk Premium?</li>
</ul>
<div class="lb-trans"><ul>
<li>下跌超过 80%，宠物保险公司 Trupanion 值得冒险溢价吗？</li>
</ul>
</div><p>Several analysts have weighed in on the stock. Weiss Ratings reissued a &#34;hold (c+)&#34; rating on shares of Palomar in a research note on Wednesday, October 8th. Evercore ISI decreased their price objective on Palomar from $168.00 to $134.00 and set an &#34;in-line&#34; rating on the stock in a report on Wednesday, October 1st. Keefe, Bruyette &amp; Woods increased their target price on Palomar from $164.00 to $170.00 and gave the company an &#34;outperform&#34; rating in a report on Tuesday, November 11th. JPMorgan Chase &amp; Co. raised their price target on Palomar from $137.00 to $145.00 and gave the stock an &#34;overweight&#34; rating in a research report on Monday, November 10th. Finally, Wall Street Zen cut Palomar from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Saturday, December 20th.</p>
<div class="lb-trans"><p>几位分析师对该股票发表了看法。Weiss Ratings 在 10 月 8 日（星期三）的研究报告中重新发布了对 Palomar 股票的 “持有（c+）” 评级。Evercore ISI 在 10 月 1 日（星期三）的报告中将 Palomar 的目标价从 168.00 美元下调至 134.00 美元，并对该股票设定了 “持平” 评级。Keefe, Bruyette &amp; Woods 在 11 月 11 日（星期二）的报告中将 Palomar 的目标价从 164.00 美元上调至 170.00 美元，并给予该公司 “跑赢大盘” 的评级。摩根大通在 11 月 10 日（星期一）的研究报告中将 Palomar 的目标价从 137.00 美元上调至 145.00 美元，并给予该股票 “超配” 的评级。最后，华尔街 Zen 在 12 月 20 日（星期六）的研究报告中将 Palomar 的评级从 “买入” 下调至 “持有”。</p>
</div><p><strong>Read Our Latest Stock Report on PLMR</strong></p>
<div class="lb-trans"><p><strong>阅读我们最新的 PLMR 股票报告</strong></p>
</div><h2>Palomar Price Performance</h2>
<div class="lb-trans"><h2>Palomar 价格表现</h2>
</div><ul>
<li>3 Small Cap Stocks That May Someday be Large Caps</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只小盘股可能有一天会成为大盘股</li>
</ul>
</div><p>Shares of NASDAQ PLMR opened at $136.29 on Thursday. The stock has a market capitalization of $3.61 billion, a P/E ratio of 21.26 and a beta of 0.50. Palomar has a one year low of $98.42 and a one year high of $175.85. The firm's 50 day simple moving average is $122.35 and its two-hundred day simple moving average is $127.96.</p>
<div class="lb-trans"><p>NASDAQ PLMR 的股票在周四以 136.29 美元开盘。该股票的市值为 36.1 亿美元，市盈率为 21.26，贝塔值为 0.50。Palomar 的 52 周低点为 98.42 美元，52 周高点为 175.85 美元。该公司的 50 日简单移动平均线为 122.35 美元，200 日简单移动平均线为 127.96 美元。</p>
</div><p>Palomar (NASDAQ:PLMR - Get Free Report) last announced its quarterly earnings data on Friday, December 16th. The company reported $0.07 earnings per share (EPS) for the quarter. Palomar had a net margin of 22.59% and a return on equity of 21.93%. The company had revenue of $65.74 million during the quarter. As a group, equities analysts expect that Palomar will post 5.99 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Palomar（纳斯达克代码：PLMR - 获取免费报告）最近于 12 月 16 日（星期五）公布了季度财报。该公司报告每股收益（EPS）为 0.07 美元。Palomar 的净利润率为 22.59%，股本回报率为 21.93%。该公司在本季度的收入为 6574 万美元。整体来看，股票分析师预计 Palomar 在当前财政年度的每股收益为 5.99 美元。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部活动</h2>
</div><p>In other Palomar news, CFO T Christopher Uchida sold 782 shares of the stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $128.84, for a total transaction of $100,752.88. Following the completion of the sale, the chief financial officer owned 7,916 shares of the company's stock, valued at $1,019,897.44. This represents a 8.99% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Mac Armstrong sold 5,000 shares of the firm's stock in a transaction on Friday, November 21st. The stock was sold at an average price of $122.86, for a total transaction of $614,300.00. Following the completion of the sale, the chief executive officer directly owned 358,388 shares in the company, valued at approximately $44,031,549.68. This trade represents a 1.38% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 14,803 shares of company stock valued at $1,768,671. 3.70% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在 Palomar 的其他新闻中，首席财务官 T Christopher Uchida 在 11 月 18 日（星期二）出售了 782 股该股票。股票以平均价格 128.84 美元出售，总交易额为 100,752.88 美元。出售完成后，首席财务官持有该公司 7916 股股票，价值 1,019,897.44 美元。这代表其持股减少了 8.99%。该交易在向 SEC 提交的文件中披露，相关信息可在 SEC 网站上找到。此外，首席执行官 Mac Armstrong 在 11 月 21 日（星期五）出售了 5000 股该公司的股票。股票以平均价格 122.86 美元出售，总交易额为 614,300.00 美元。出售完成后，首席执行官直接持有该公司 358,388 股股票，价值约 44,031,549.68 美元。此交易代表其持股减少了 1.38%。该交易的披露信息可在 SEC 文件中找到。在上个季度，内部人士共出售了 14,803 股公司股票，价值 1,768,671 美元。3.70% 的股票由公司内部人士持有。</p>
</div><h2>Institutional Trading of Palomar</h2>
<div class="lb-trans"><h2>Palomar 的机构交易</h2>
</div><p>Several large investors have recently modified their holdings of PLMR. Dynamic Technology Lab Private Ltd bought a new position in shares of Palomar during the first quarter valued at approximately $314,000. Advisors Asset Management Inc. boosted its holdings in Palomar by 867.0% in the first quarter. Advisors Asset Management Inc. now owns 8,229 shares of the company's stock valued at $1,128,000 after acquiring an additional 7,378 shares in the last quarter. Trexquant Investment LP purchased a new position in Palomar during the 1st quarter valued at $591,000. Coppell Advisory Solutions LLC raised its holdings in Palomar by 3,912.3% in the 1st quarter. Coppell Advisory Solutions LLC now owns 8,787 shares of the company's stock worth $1,205,000 after purchasing an additional 8,568 shares in the last quarter. Finally, Alliancebernstein L.P. raised its holdings in Palomar by 322.4% in the 1st quarter. Alliancebernstein L.P. now owns 127,383 shares of the company's stock worth $17,462,000 after purchasing an additional 97,226 shares in the last quarter. 90.25% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>几家大型投资者最近调整了对 PLMR 的持股。Dynamic Technology Lab Private Ltd 在第一季度购买了 Palomar 的新头寸，价值约 314,000 美元。Advisors Asset Management Inc.在第一季度将其在 Palomar 的持股增加了 867.0%。Advisors Asset Management Inc.现在拥有 8229 股该公司的股票，价值 1,128,000 美元，此前在上个季度又购买了 7378 股。Trexquant Investment LP 在第一季度购买了 Palomar 的新头寸，价值 591,000 美元。Coppell Advisory Solutions LLC 在第一季度将其在 Palomar 的持股增加了 3912.3%。Coppell Advisory Solutions LLC 现在拥有 8787 股该公司的股票，价值 1,205,000 美元，此前在上个季度又购买了 8568 股。最后，Alliancebernstein L.P.在第一季度将其在 Palomar 的持股增加了 322.4%。Alliancebernstein L.P.现在拥有 127,383 股该公司的股票，价值 17,462,000 美元，此前在上个季度又购买了 97,226 股。90.25% 的股票由机构投资者持有。</p>
</div><h2>About Palomar</h2>
<div class="lb-trans"><h2>关于 Palomar</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Palomar Holdings, Inc NASDAQ: PLMR is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.</p>
<div class="lb-trans"><p>Palomar Holdings, Inc. 纳斯达克：PLMR 是一家专注于为美国自筹资金的雇主健康计划提供医疗止损保险和相关行政服务的专业保险控股公司。该公司通过两个主要业务部门——医疗止损和专业项目管理，提供量身定制的风险保护和全面的项目管理。</p>
</div><p>In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.</p>
<div class="lb-trans"><p>在其医疗止损部门，Palomar 承保旨在保护自保雇主免受超过预定保留水平的灾难性医疗索赔的超额和总额止损保单。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Palomar</li>
<li>Do not delete, read immediately</li>
<li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li>
<li>Can Any Expenses Be Deducted From Capital Gains Tax?</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
<li>Forget AI, This Will Be the Next Big Tech Breakthrough</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Palomar 更好</li>
<li>请勿删除，立即阅读</li>
<li>投资者警报：微型 “3 美元人工智能奇迹股票” 即将爆发</li>
<li>是否可以从资本利得税中扣除任何费用？</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
<li>忘记人工智能，这将是下一个重大科技突破</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UExNUg" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=PLMR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Palomar Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Palomar 吗？</h2>
</div><p>Before you consider Palomar, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Palomar 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Palomar wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Palomar 并不在名单上。</p>
</div><p>While Palomar currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Palomar 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Palomar Holdings, Inc.（纳斯达克股票代码：PLMR）被分析师给予 “适度买入” 的平均评级